fbpx
01 / 05
Google Founder’s Airship Gets FAA Clearance

IEEE Spectrum | Air Transport

Google Founder’s Airship Gets FAA Clearance

“After extensive flight testing in California, the Pathfinder 1 will transit to the former Goodyear Airdock airship hangar in Akron, Ohio, which the company has acquired as its future manufacturing location. There, an even larger 180-meter long airship, the Pathfinder 3, is already under development.

Ultimately, LTA intends its aircraft to be used for humanitarian missions, deploying cargo and personnel to areas that are inaccessible by road. Brin runs a separate non-profit, called Global Support and Development, that has already carried out such missions by sea, in the Caribbean, Latin American and the South Pacific.”

From IEEE Spectrum.

S&P Global | Energy & Natural Resources

US DOE Finalizes Rules to Speed Transmission Permitting

“Under the program, the DOE will coordinate efforts across eight other agencies to prepare a single environmental review document for transmission developers seeking federal approvals. The program also establishes a two-year timeline for the permitting process.

‘The CITAP program gives transmission developers a new option for a more efficient review process, a major step to provide increased confidence for the sector to invest in new transmission lines,’ the DOE said in a fact sheet.

A second final rule creates a categorical exclusion — the simplest form of review under the National Environmental Policy Act — for transmission projects that use existing rights of way, such as reconductoring projects, as well as solar and energy storage projects on already disturbed lands.”

From S&P Global.

Washington Post | Health & Medical Care

FDA Authorizes AI-Driven Test to Predict Sepsis in Hospitals

“Bobby Reddy Jr. roamed a hospital as he built his start-up, observing how patient care began with a diagnosis and followed a set protocol. The electrical engineer thought he knew a better way: an artificial intelligence tool that would individualize treatment.

Now, the Food and Drug Administration has greenlighted such a test developed by Reddy’s company, Chicago-based Prenosis, to predict the risk of sepsis — a complex condition that contributes to at least 350,000 deaths a year in the United States. It is the first algorithmic, AI-driven diagnostic tool for sepsis to receive the FDA’s go-ahead.”

From Washington Post.